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Stroke is the third leading cause of death in the United
States. In 1999, 167,366 Americans died from strokes. An
estimated 600,000 people suffer a new or recurrent stroke
per year, and 15% to 30% remain permanently disabled.
This has led to staggering costs to the health care system,
with an annual cost (direct and indirect) of stroke in the
United States in 2002 of $49.4 billion.1 Approximately
50% of ischemic strokes are considered thrombotic.2 These
infarctions are caused by occlusion of large intracerebral or
extracerebral vessels, which may be related to carotid artery
disease. The remainder are caused by emboli from other
sources such as the heart and are associated with cardiac
arrhythmias, or they are considered lacunar infarcts.2 The
lacunar infarcts are usually from intrinsic small vessel disease
of the brain or less frequently from atheromatous or em-
bolic disease of larger perforator vessels, often related to
hypertension.3
Despite the proven benefit of carotid endarterectomy
in patients with and without neurologic symptoms4,5 and
the fact that 80% of strokes occur in asymptomatic patients,
widespread screening of patients for carotid disease with
the use of a duplex scan has not been accepted in the United
States, largely because of the issue of cost-effectiveness. In
fact, the estimated cost of screening every American over
the age of 65 with a standard carotid duplex examination at
$300 per test would be $10.4 billion annually.1 The ratio-
nale of major third-party payers has been that massive
screening at great cost would be necessary to identify
relatively few patients at risk of stroke from carotid artery
disease. Holloway et al6 reviewed studies on cost-effective-
ness of stroke evaluation and research. They concluded that
cost-effectiveness estimates improved when subjects with a
higher prevalence of underlying disease were tested. These
models included costs of standard duplex ultrasound exam-
inations of the carotid arteries, which can cost $300 to
$400 per examination with direct and indirect costs.
Several authors have described accurate, modified ca-
rotid duplex scans that can be performed quickly and at
lower cost.7,8 At our institution, a modified, rapid duplex
scan was developed as part of a stroke screening program,
and its accuracy was verified by a pilot study. A select group
of subjects was then screened and evaluated. The selection
criteria were based on literature defining populations with
increased prevalence of carotid artery disease. Many of
these studies have focused on specific populations such as
those with existing peripheral vascular disease, aortic aneu-
rysm disease, or coronary artery disease.9-23 Few have ex-
amined asymptomatic patients in unselected subjects.24,25
In these studies, increased age, smoking, coronary artery
disease, and hypercholesterolemia have all been associated
with increased incidence of carotid artery disease to various
extents. The goal of this study was to identify risk factors
predictive of occult carotid artery stenosis in patients with
no history of stroke or transient ischemia attack (TIA) and
to define a subpopulation for which efficient screening for
carotid stenosis would be practical as a means of stroke
prevention.
PATIENTS AND METHODS
Development of a modified duplex scan. The mod-
ified duplex scan consisted of ultrasound imaging of the
distal common carotid artery, bulb, and proximal internal
and external carotid arteries, with evaluation of a Doppler
signal for 3 to 5 beats in each location. Stenosis was
interpreted as greater or less than 50% of luminal diameter
based on Doppler-derived velocities. Peak systolic velocities
of greater than 120 cm per second at the internal carotid
artery were interpreted as greater than 50% luminal diame-
ter reduction, on the basis of the University of Washington
criteria.26 These criteria have been used regularly in the
vascular laboratory at New York University Medical Cen-
ter, and they have been periodically validated against con-
ventional angiography and magnetic resonance angiogra-
phy as part of the accreditation process of the Intersocietal
Commission for the Accreditation of Vascular Laboratories
(ICAVL). The criteria used in the New York University
vascular laboratory conform completely to those of Taylor
and Strandness.26
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These criteria were further validated for the modified
duplex scan in a separate pilot study in which a double-
blind examination was performed by using both the mod-
ified carotid duplex examination and the standard duplex
technique. The subjects for the pilot study were separate
from those in the screening study. The pilot study was
double-blinded in that interpreting physicians and techni-
cians performing the modified duplex scan did not know
the results of the standard duplex scan for the same patient
and vice versa. Length of time to perform each examination
and degree of stenosis were compared in the validation
study. Both modified and standard carotid duplex exami-
nations were performed by experienced registered vascular
technicians in an ICAVL-accredited laboratory.
Screening protocol. Subjects were eligible for screen-
ing if they were at least 60 years of age and had at least one
of the following risk factors: history of coronary artery
disease, previously diagnosed hypertension, current smok-
ing, and a family history of stroke in a first-degree relative.
The subjects were recruited at large by the use of advertise-
ments in local newspapers and community news bulletins.
They had not been seen in the Vascular Clinic for other
reasons. Once selected, each subject underwent the follow-
ing screening for the three proximate or immediate causes
of stroke: a modified duplex scan by a registered vascular
technician, an EKG rhythm strip, and a blood pressure
measurement. Screening tests were free of charge to pa-
tients, and they took place on several days of screening
clinics between June 2001 and September 2002. The study
was approved by the New York University School of Med-
icine Institutional Review Board, and all patients signed
informed consent. Additional medical history and other
demographic factors were recorded at the time of screen-
ing, including hypercholesterolemia (based on patient his-
tory or the use of cholesterol-lowering medication), gen-
der, age, and race. Data were maintained in a computerized
database and analyzed by means of the statistical software
package SPSS (SPSS Inc, Chicago, Ill). Statistical compar-
isons were performed using the two-tailed Student t test for
comparison of continuous variables, and 2 analysis for
comparison of discrete variables. Multivariate analysis was
performed using logistic regression. On the basis of the
univariate and multivariate analyses, a model was designed
using logistic regression and prespecified contrast state-
ments for multiple comparisons to assess the relationship
between the number of risk factors present and occult
carotid stenosis. A result was considered statistically signif-
icant with a P value of .05.
RESULTS
Results of modified duplex scan validation
study. In the verification study, 166 carotid arteries were
examined. There were 16 arteries with50% stenosis iden-
tified by both modified and standard duplex scans. There
were five false-negative modified scans and no false-positive
modified scans. In 145 arteries, both the modified and
standard duplex scans showed 50% carotid stenosis.
When compared with a full, standard carotid duplex scan,
the modified carotid duplex examination had a positive
predictive value of 100%, a negative predictive value of 97%,
and an accuracy of 97%. Sensitivity and specificity were 76%
and 100%, respectively. No high-grade (80%) stenoses or
total occlusions of the internal carotid arteries were incor-
rectly interpreted. The average time for the modified scan
was 94  5 seconds (SEM) with a range of 32 to 270
seconds. This was significantly less than the average time for
the standard scan of 690 30 seconds (SEM) with a range
of 249 to 1423 seconds using a two-tailed Student t test (P
 .0001). The median time for the modified duplex scan
was 85 seconds, and the median time for the standard scan
was 613 seconds.
Results of stroke screening. Screening for carotid
stenosis was performed on 394 patients. This group of
patients was separate from the group of 83 patients evalu-
ated in the duplex validation study. Among the 394 pa-
tients, 38 patients (9.6%) had either unilateral or bilateral
carotid artery stenosis of 50%. The average age of
screened patients was 71.3 years (range, 60-90 years).
Overall, 31.9% of patients were men. Risk factors evaluated
included smoking, hypertension, cardiac disease, and hy-
percholesterolemia, age, gender, family history of stroke,
and race. The prevalence of each of these risk factors in the
subjects is listed in Table I. By univariate 2 analysis, only
hypertension (P  .01) and cardiac disease (P  .01) were
associated with an increased prevalence of occult carotid
stenosis. A trend toward statistical significance was noted
Table I. Patient demographics (Total N  394)
Factor No. % of total
Carotid stenosis
 50%
Carotid stenosis
 50% P value
Hypercholesterolemia 178 45.2 21 157 .25
Family history of stroke 200 50.8 12 188 .02*
Hypertension 253 64.2 32 221 .01
Coronary artery disease 68 17.3 11 57 .07
Cardiac disease (all) 111 28.2 18 93 .01
Gender (% male) 126 31.9 11 115 .81
Current smoker 34 8.4 6 28 .17
Caucasian race 340 86.3 35 305 .39
2 analysis for all P values.
*P value shows statistical significance for an association of a family history of stroke with 50% stenosis.
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for hypercholesterolemia (P .25) and current smoking (P
 .17). Family history of stroke was associated with a
decreased prevalence of occult carotid stenosis. There was
no statistically significant difference between ages of sub-
jects with and without carotid stenosis by Student t test. By
multivariate analysis, independent predictors of carotid ar-
tery stenosis included hypertension (odds ratio, 3.0; 95%
CI, 1.2-7.5) and cardiac disease (odds ratio 2.4; 95% CI,
1.2-4.9).
Development of a model. On the basis of the result of
univariate and multivariate analyses, the following four risk
factors were entered into a logistic regression analysis with
prespecified contrast statements: hypertension, cardiac dis-
ease, current smoking, and hypercholesterolemia. The
presence of one (P  .01), two (P  .01), and three (P 
.05) risk factors showed a statistically significant effect on
the presence of occult carotid stenosis when compared with
no risk factor present. If norisk factors was present, the
prevalence of carotid stenosis was 1.8%. This increased to
5.8% with one risk factor, 13.5% with two risk factors, and
16.7% with three risk factors Two of three patients with all
four risk factors had carotid stenosis (66.7%). This is shown
in Table II.
DISCUSSION
The effectiveness of carotid endarterectomy for the
prevention of strokes has been well established by large
multicenter, randomized trials, provided that the surgical
treatment is offered with a low morbidity.4,5 Furthermore,
treatment of stroke after it occurs has been poor, with a 28%
mortality and permanent disability in another 15% to 30%
of patients.1 However, widespread screening for carotid
stenosis has not been accepted. This is largely due to the
cost of screening by means of a standard duplex examina-
tion and the relatively low incidence of significant carotid
stenosis in the general population. Screening for other
disease entities has been well established, such as colon,
prostate, cervical, and breast cancer. These screenings have
been recommended for specific groups of subjects on the
basis of risk factors such as age and family history. It is not
unreasonable to consider similar prerequisites as necessary
to define a group of subjects who would most benefit from
screening for occult carotid artery stenosis. Qureshi et al24
screened an unselected patient population and found that
age greater than 65 years, current smoking, hypercholes-
terolemia, and coronary artery disease were associated with
occult carotid stenosis of 60% by standard duplex scan-
ning. Using a standard duplex scan as a screening test, those
authors suggested that routine screening for carotid steno-
sis might prove to be cost-effective in a high-risk group with
these risk factors. The results of the current study are
consistent with those of Qureshi et al, although the current
study also found hypertension to be an independent pre-
dictor of occult carotid stenosis. Forsblad et al25 evaluated
an unselected middle-aged group of subjects and found
that hypertension was also a predictor of carotid endarter-
ectomy.
In the present study, a family history of stroke was
actually associated with a decreased prevalence of occult
carotid stenosis by univariate analysis. It is difficult to draw
conclusions that such a history is in any way protective of
carotid stenosis. The unexpected finding of a negative
association between the family history of stroke and occult
carotid stenosis may be related to fact that the presence of
this risk factor was based entirely on patient history, which
can be difficult to confirm.
Several authors have demonstrated the cost-effective-
ness of carotid endarterectomy, particularly when periop-
erative morbidity is low and the procedure was not per-
formed on very elderly patients.27-29 These studies have not
included the cost of widespread screening, particularly for
asymptomatic patients. Others have examined the cost-
effectiveness of screening.30-32 Most of these authors have
used the method of quality-adjusted life years. In general, a
cost-effectiveness ratio of less than $50,000 suggests an
intervention is cost-effective, and cost-effectiveness ratios
of between $50,000 and $100,000 suggest that an inter-
vention is borderline cost-effective.33 There have been
disparate results, largely depending on the population
screened and the assumed cost of various interventions. Lee
et al 31 developed a model using a general population of
men over age 65, and found that screening for carotid
stenosis was not cost effective. However, these authors used
the cost of conventional angiography in their assessment,
and they used charges as a measure of cost, which may have
further affected their results. Others have found that
screening is cost-effective if it is performed as a one-time
screening as opposed to annual screening.30 As noted by
Holloway et al6 in a review of stroke prevention studies, the
underlying trend was that the higher the prevalence of the
occult process in a given population, the more cost effective
screening becomes. Obuchowski et al34 found that the use
of duplex ultrasound was cost-effective in screening a pop-
ulation with at least a 20% prevalence of significant carotid
stenosis. Yin and Carpenter32 performed an extensive cost-
effectiveness analysis and found that screening was cost-
effective if the prevalence of carotid stenosis was 4.5% or
more, the specificity of the screening test (duplex ultra-
sound) was 91% or more, the stroke rate of patients who
were medically treated was 3.3% or more, the relative risk
reduction of stroke was 37% or more, and the cost of
ultrasound screening was $300 or less. Screening with or
without arteriographic verification did not significantly af-
fect the results. In the current study, we did not perform
quality-adjusted life years analysis, and specific cost analysis
was not performed. However, there was a 9.6% prevalence
of carotid stenosis, and the modified duplex scan had a
Table II. Prevalence of occult carotid stenosis associated
with risk factors
No. of risk factors 0 1 2 3 4
No. of patients 54 156 133 48 3
% carotid stenosis 1.8 5.8 13.5 16.7 66.7
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specificity of 100%. ACAS results showed a 55% risk reduc-
tion for stroke with carotid endarterectomy.4 The periop-
erative stroke rates for asymptomatic patients at many indi-
vidual institutions, including our own, has been shown to
be well below those of ACAS.35,36
There are often no warning signs of stroke, and once
symptoms begin, rarely can treatment be obtained in time
to reverse the course of the neurologic insult. Thrombolysis
of intracerebral clots has been show to be effective, but this
is only available to the relatively few patients who can be
evaluated at a major medical center in the first few hours
after the onset of symptoms.37 Once a stroke has occurred,
an attempt is made to define the underlying cause, and
treatment is directed toward rehabilitation and prevention
of further strokes on the basis of the identified cause.
So-called “waiting” for a clinical indication of carotid ste-
nosis can be catastrophic, as that the first manifestation is
often a severe stroke. The best treatment for stroke is
prevention. Public awareness programs have been spon-
sored by the American Stroke Association and the National
Institute of Health. These programs have educated the
public about the causes of stroke and the need to treat
underlying conditions, such as hypertension.
Screening for carotid artery stenosis has been labor
intensive, requiring bulky duplex ultrasound equipment
that increases cost and often requires patients to have
appointments with physicians or clinics. The modified ca-
rotid duplex scan may significantly reduce the costs of
screening, and the latest generation of portable duplex
machines may make community outreach programs more
accessible to the public. This study has identified risk factors
associated with increased prevalence of carotid stenosis. In
this high-risk population, screening for carotid artery ste-
nosis may be worthwhile when even one of these risk factors
is present. As advances in duplex ultrasound technology
continue to improve the ability to deliver this screening to
the public at large, such screening could have a major
impact on stroke prevention.
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